Cargando…
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients
BACKGROUND: SWOG initiated a cancer care delivery research study of virus infection rates among newly diagnosed cancer patients. This study will inform viral screening guidelines in oncology clinics. METHODS: In a first step ‘vanguard’ phase, we evaluated the feasibility of multiple study procedures...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864045/ https://www.ncbi.nlm.nih.gov/pubmed/26952901 http://dx.doi.org/10.2217/fon-2015-0076 |
_version_ | 1782431571516588032 |
---|---|
author | Unger, Joseph M Hershman, Dawn L Arnold, Kathryn B Loomba, Rohit Chugh, Rashmi Hwang, Jessica P O'Rourke, Mark A Bhadkamkar, Nishin A Wang, Lili X Siegel, Abby B Cooley, Timothy P Berenberg, Jeffrey L Bridges, Benjamin B Ramsey, Scott D |
author_facet | Unger, Joseph M Hershman, Dawn L Arnold, Kathryn B Loomba, Rohit Chugh, Rashmi Hwang, Jessica P O'Rourke, Mark A Bhadkamkar, Nishin A Wang, Lili X Siegel, Abby B Cooley, Timothy P Berenberg, Jeffrey L Bridges, Benjamin B Ramsey, Scott D |
author_sort | Unger, Joseph M |
collection | PubMed |
description | BACKGROUND: SWOG initiated a cancer care delivery research study of virus infection rates among newly diagnosed cancer patients. This study will inform viral screening guidelines in oncology clinics. METHODS: In a first step ‘vanguard’ phase, we evaluated the feasibility of multiple study procedures. Site investigators were surveyed to obtain feedback on study implementation. RESULTS: Much higher enrollment occurred at sites where all physicians participated and viral testing was performed as routine practice. These procedures will be required going forward. Additional protocol changes based on site investigator input were implemented. CONCLUSION: This multistep protocol design process illustrates how cancer care delivery research studies can adapt to real-world strategies and procedures that exist at community clinics where the predominance of cancer patients are treated. |
format | Online Article Text |
id | pubmed-4864045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48640452017-05-01 Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients Unger, Joseph M Hershman, Dawn L Arnold, Kathryn B Loomba, Rohit Chugh, Rashmi Hwang, Jessica P O'Rourke, Mark A Bhadkamkar, Nishin A Wang, Lili X Siegel, Abby B Cooley, Timothy P Berenberg, Jeffrey L Bridges, Benjamin B Ramsey, Scott D Future Oncol Research Article BACKGROUND: SWOG initiated a cancer care delivery research study of virus infection rates among newly diagnosed cancer patients. This study will inform viral screening guidelines in oncology clinics. METHODS: In a first step ‘vanguard’ phase, we evaluated the feasibility of multiple study procedures. Site investigators were surveyed to obtain feedback on study implementation. RESULTS: Much higher enrollment occurred at sites where all physicians participated and viral testing was performed as routine practice. These procedures will be required going forward. Additional protocol changes based on site investigator input were implemented. CONCLUSION: This multistep protocol design process illustrates how cancer care delivery research studies can adapt to real-world strategies and procedures that exist at community clinics where the predominance of cancer patients are treated. Future Medicine Ltd 2016-05 2016-03-08 /pmc/articles/PMC4864045/ /pubmed/26952901 http://dx.doi.org/10.2217/fon-2015-0076 Text en © Joseph M Unger This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Research Article Unger, Joseph M Hershman, Dawn L Arnold, Kathryn B Loomba, Rohit Chugh, Rashmi Hwang, Jessica P O'Rourke, Mark A Bhadkamkar, Nishin A Wang, Lili X Siegel, Abby B Cooley, Timothy P Berenberg, Jeffrey L Bridges, Benjamin B Ramsey, Scott D Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title | Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title_full | Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title_fullStr | Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title_full_unstemmed | Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title_short | Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
title_sort | stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864045/ https://www.ncbi.nlm.nih.gov/pubmed/26952901 http://dx.doi.org/10.2217/fon-2015-0076 |
work_keys_str_mv | AT ungerjosephm stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT hershmandawnl stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT arnoldkathrynb stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT loombarohit stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT chughrashmi stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT hwangjessicap stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT orourkemarka stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT bhadkamkarnishina stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT wanglilix stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT siegelabbyb stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT cooleytimothyp stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT berenbergjeffreyl stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT bridgesbenjaminb stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients AT ramseyscottd stepwisedevelopmentofacancercaredeliveryresearchstudytoevaluatetheprevalenceofvirusinfectionsincancerpatients |